Gene Therapy Stocks Take Beating On Bad News For Celladon
April 27, 2015 at 13:49 PM EDT
Biotech stocks took a beating Monday after Celladon Corp (NASDAQ: CLDN) said its heart failure drug Mydicar is a bust. Celladon ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.